"Antisera" With Potential To Treat Covid Gets Nod For Phase-1 Human Trials

The Drugs Controller General of India has given permission for conducting Phase-1 human clinical trial for an "antisera" that was developed by injecting inactivated SARS-CoV-2 in horses and can be a...